These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8213718)

  • 1. Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: evidence of an altered circadian rhythm.
    Buzzelli G; Dattolo P; Pinzani M; Brocchi A; Romano S; Gentilini P
    Am J Gastroenterol; 1993 Oct; 88(10):1744-8. PubMed ID: 8213718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: a preliminary prospective study.
    Bassanello M; De Palo EF; Lancerin F; Vitale A; Gatti R; Montin U; Ciarleglio FA; Senzolo M; Burra P; Brolese A; Zanus G; D'Amico DF; Cillo U
    Liver Transpl; 2004 May; 10(5):692-8. PubMed ID: 15108263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis].
    Mangieri E; Tosti-Croce C; Tanzilli G; Barillà F; Nardi M; Poggi M; Ciavolella M; Farinelli A; Mangiaracina F; Campa PP
    Cardiologia; 1996 May; 41(5):449-53. PubMed ID: 8767634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA expression patterns for GH, PRL, SL, IGF-I and IGF-II during altered feeding status in rabbitfish, Siganus guttatus.
    Ayson FG; de Jesus-Ayson EG; Takemura A
    Gen Comp Endocrinol; 2007 Jan; 150(2):196-204. PubMed ID: 16978626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific alterations in insulin-like growth factor-I concentrations in response to 3,3',5-triiodo-L-thyronine supplementation in the growth hormone receptor-deficient sex-linked dwarf chicken.
    Vasilatos-Younken R; Dunnington EA; Siegel PB; McMurtry JP
    Gen Comp Endocrinol; 1997 Jan; 105(1):31-9. PubMed ID: 9000465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance.
    Shmueli E; Miell JP; Stewart M; Alberti KG; Record CO
    Hepatology; 1996 Jul; 24(1):127-33. PubMed ID: 8707251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of alcohol and liver cirrhosis on the GH-IGF-I axis.
    Santolaria F; González-González G; González-Reimers E; Martínez-Riera A; Milena A; Rodgíguez-Moreno F; González-García C
    Alcohol Alcohol; 1995 Nov; 30(6):703-8. PubMed ID: 8679009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in a patient with acromegaly and high serum levels of insulin-like growth factor I: report of a case.
    Yamaguchi M; Tate G; Yoshizawa Y; Midorikawa T; Sanada Y; Kumada K
    Surg Today; 2002; 32(11):1008-11. PubMed ID: 12444442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IGF-1, IGF-2 and IGFBP-3 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma.
    Rehem RN; El-Shikh WM
    Hepatogastroenterology; 2011; 58(107-108):949-54. PubMed ID: 21830422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation.
    Holt RI; Baker AJ; Jones JS; Miell JP
    Pediatr Transplant; 1998 Feb; 2(1):76-84. PubMed ID: 10084765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
    Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
    Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian aspects of growth hormone-insulin-like growth factor axis function in patients with lung cancer.
    Mazzoccoli G; Sothern RB; Pazienza V; Piepoli A; Muscarella LA; Giuliani F; Tarquini R
    Clin Lung Cancer; 2012 Jan; 13(1):68-74. PubMed ID: 21729653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.